Gastrointestinal Cancer

Top Story

FDA grants orphan drug designation to BPM31510 for pancreatic cancer

January 23, 2018
Meeting News

Pembrolizumab induces durable responses in advanced liver cancer

January 23, 2018
Pembrolizumab treatment led to durable OS and PFS among patients with advanced hepatocellular carcinoma who previously progressed on sorafenib, according to results of…

Smartphone app helps screen for pancreatic cancer

January 23, 2018
Researchers at University of Washington have developed a smartphone app designed to detect jaundice, a common early symptom of pancreatic cancer. Investigators assessed…
In the Journals

Second reminder improves uptake in colon cancer screenings

January 22, 2018
Patients in the U.K. were more likely to undergo flexible sigmoidoscopy screening if they received a second follow-up reminder that included a brochure that addressed…
More Headlines »

Addressing Common Patient Concerns Regarding Biosimilars

This activity is supported by an educational grant from Pfizer, Inc.

As more biosimilars are approved for use in the United States, greater emphasis is needed on educating patients about…
More »
Meeting News Coverage

VIDEO: Atezolizumab, cobimetinib in combination demonstrate activity in colon cancer

September 7, 2016
More »
Resource Centers
San Antonio Breast Cancer Symposium

San Antonio Breast Cancer Symposium


EGFR-mutated NSCLC: Differentiating Options to Optimize Patient Care

This educational activity is supported by an independent medical educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.

Lung cancer is the second most commonly diagnosed cancer within the United States and accounts for approximately 25% of…
More »